Tryptophan metabolites generated by indoleamine-2,3-dioxygenase (IDO) and tryptophan-2,3-dioxygenase (TDO) have been shown to promote tumor growth and immune evasion in peritoneal cancers [74,75]. Here, TDO2 is linked to peritoneum cancer.